COMPASS THERAPEUTICS, INC.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Jun 2018 | 19.7% | 19.7% | -117.2% |
| Sep 2018 | 16.6% | 16.6% | -349.8% |
| Dec 2018 | 0.0% | 0.0% | -216.8% |
| Mar 2019 | 11.3% | 11.3% | -221,352.2% |
| Jun 2019 | 8.5% | 8.5% | -181,031.6% |
| Sep 2019 | 7.6% | 7.6% | -969,614.5% |
| Dec 2019 | -0.1% | -0.1% | 0.0% |
| Mar 2020 | 5.1% | 5.1% | -170,947.9% |
| Jun 2020 | -10.4% | -9.4% | -7.9% |
| Sep 2020 | -19.3% | -17.9% | -15.1% |
| Mar 2021 | -22.2% | -22.2% | -15.4% |
| Jun 2021 | -193.3% | -193.3% | -136.5% |
| Sep 2021 | -25.0% | -25.0% | -17.1% |
| Mar 2022 | -5.3% | -5.3% | -4.9% |
| Jun 2022 | -6.7% | -6.7% | -6.1% |
| Sep 2022 | -10.3% | -10.3% | -9.4% |
| Mar 2023 | -4.5% | -4.5% | -4.2% |
| Jun 2023 | -6.7% | -6.7% | -6.3% |
| Sep 2023 | -6.2% | -6.2% | -5.9% |
| Mar 2024 | -6.9% | -6.9% | -6.7% |
| Jun 2024 | -8.9% | -8.9% | -8.4% |
| Sep 2024 | -7.6% | -7.6% | -7.0% |
| Mar 2025 | -15.1% | -15.1% | -12.7% |
| Jun 2025 | -21.3% | -21.3% | -17.0% |
| Sep 2025 | -6.8% | -6.8% | -6.2% |
| Mar 2026 | -9.8% | -9.8% | -8.9% |
| Jun 2026 | -15.1% | -15.1% | -13.2% |